Literature DB >> 16511838

Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder.

Kazuhiko Nakamura1, Kazuo Yamada, Yoshimi Iwayama, Tomoko Toyota, Aizou Furukawa, Takahiro Takimoto, Hayato Terayama, Kazuhiko Iwahashi, Nori Takei, Yoshio Minabe, Yoshimoto Sekine, Katsuaki Suzuki, Yasuhide Iwata, Anitha Pillai, Yurie Nakamoto, Kazutaka Ikeda, Mitsunobu Yoshii, Isao Fukunishi, Takeo Yoshikawa, Norio Mori.   

Abstract

Panic disorder (PD) is the repeated sudden occurrence of panic attacks, episodes characterized by psychological symptoms. Peripheral benzodiazepine receptor (PBR) is closely associated with personality traits for anxiety tolerance, and that it holds promise as a biological marker of stressful conditions. We have performed association analyses using the polymorphism to determine the PBR in PD. We screened the subjects for sequence variations within the 5' region, the coding region (exons 2-4), and the 3' noncoding region. One novel missense variant in exon 4, derived from the nucleotide transition in codon 162 (CGT --> CAT:485G > A) resulting in an arginine-to-histidine (Arg --> His) change, was detected in these subjects. The 485G > polymorphism of the PBR gene was analyzed in 91 PD patients and 178 controls. The genotypic and allelic analyses of the 485G > A revealed significant differences between the panic patients and the comparison subjects (P = 0.021 and 0.014, respectively). The present study provides new and important evidence that variation in the PBR gene influences susceptibility to PD. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511838     DOI: 10.1002/ajmg.b.30211

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  16 in total

Review 1.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

Review 2.  Translocator protein (18 kDa): an update on its function in steroidogenesis.

Authors:  V Papadopoulos; J Fan; B Zirkin
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

3.  Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism.

Authors:  Fei Li; Jian Liu; Yi Zheng; R Michael Garavito; Shelagh Ferguson-Miller
Journal:  Science       Date:  2015-01-30       Impact factor: 47.728

Review 4.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 5.  Evolving understanding of translocator protein 18 kDa (TSPO).

Authors:  Fei Li; Jian Liu; R Michael Garavito; Shelagh Ferguson-Miller
Journal:  Pharmacol Res       Date:  2015-04-13       Impact factor: 7.658

6.  Regulation of Anxiety and Depression by Mitochondrial Translocator Protein-Mediated Steroidogenesis: the Role of Neurons.

Authors:  Anna M Barron; Makoto Higuchi; Satoko Hattori; Seiji Kito; Tetsuya Suhara; Bin Ji
Journal:  Mol Neurobiol       Date:  2020-09-29       Impact factor: 5.590

7.  Perspectives in TSPO PET Imaging for Neurologic Diseases.

Authors:  Yoo Sung Song
Journal:  Nucl Med Mol Imaging       Date:  2019-11-16

8.  Genetic and environmental factors in complex neurodevelopmental disorders.

Authors:  K M J van Loo; G J M Martens
Journal:  Curr Genomics       Date:  2007-11       Impact factor: 2.236

9.  Effects of genetic variants in the TSPO gene on protein structure and stability.

Authors:  Vladimir M Milenkovic; Stefanie Bader; Daniel Sudria-Lopez; Ramona Siebert; Caroline Brandl; Caroline Nothdurfter; Bernhard H F Weber; Rainer Rupprecht; Christian H Wetzel
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

10.  Expression and purification of the mammalian translocator protein for structural studies.

Authors:  Elisabeth Graeber; Volodymyr M Korkhov
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.